Modified FOLFIRINOX Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

Onconic Therapeutics Inc.1
EXACT Therapeutics AS1

Indications

Cancer2
Locally Advanced Pancreatic Adenocarcinoma1
Pancreatic Ductal Adenocarcinoma1

Other1 trial

Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer

Phase 1/2

Scottsdale, Arizona1 trial

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

HonorHealth Research Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.